This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Derek Lowe
Introduction
Derek Lowe is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer and other hyperproliferative diseases. His work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Derek Lowe holds a patent for Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors. This invention relates to novel compounds that are designed to target specific pathways involved in cancer progression. The patent outlines pharmaceutical compositions containing these compounds and describes methods of treatment utilizing them for cancer therapy.
Career Highlights
Lowe is currently associated with Bayer Intellectual Property GmbH, where he continues to innovate and contribute to the field of drug development. His expertise in medicinal chemistry has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Derek Lowe has collaborated with esteemed colleagues such as Stephen J. O'Connor and Jacques P. Dumas. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Derek Lowe's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his commitment to advancing cancer treatment. His work continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile